Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -9 of 9 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor				Phase III				SJCRH-SJMB03 NCT00085202
	Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors				Phase III				CHLA-HEAD-START-III CHLA-HSIII, CHLA-2004-020, CHLA-04.020, NCT00392886, UMN-MT2004-06
	Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma				Phase II				MGH-99-271 NCT00105560
	Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer				Phase II				MSKCC-05122 NCT00445965
	Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors				Phase II				3368 NCT00576537
	Melphalan and Mannitol in Treating Patients With Central Nervous System Cancer				Phase I				OHSU-1299 OHSU-ONC-98018-L, OHSU-4834, NCT00253721
	Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors				Phase I				2004-0079 NCT00502892
	Bone Marrow Radiation Therapy Followed by Busulfan, Melphalan, Thiotepa, and an Autologous Stem Cell Transplant in Treating Patients With High-Risk or Relapsed Solid Tumors				Phase I				UMN-2005LS023 UMN-2005LS023, UMN-MT2004-30, NCT00623077
	Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Central Nervous System Tumors				No phase specified				SJCRH-SJYC07 SJYC07, NCT00602667

| | | | | | | |

A Service of the National Cancer Institute